Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.
Ataka T, Kimura N, Kaneko N, Masuda T, Takeuchi Y, Yabuuchi K, Mizukami T, Takeuchi T, Ito T, Tasai H, Miyagawa T, Hanai S, Iwamoto S, Matsubara E.
Ataka T, et al. Among authors: matsubara e.
Alzheimers Dement (N Y). 2024 Oct 10;10(4):e70008. doi: 10.1002/trc2.70008. eCollection 2024 Oct-Dec.
Alzheimers Dement (N Y). 2024.
PMID: 39748849
Free PMC article.